PubMed for id: 10785

Year	Number of Results
2000	1
2002	2
2003	1
2004	2
2005	3
2006	3
2007	1
2008	1
2010	1
2011	2
2012	2
2014	3
2015	4
2016	1
2017	5
2018	2
2019	2
2020	1
2021	7
2022	4
2023	10
2024	1

1

Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer.

Zeng H, Xu S, Xia E, Hirachan S, Bhandari A, Shen Y. Zeng H, et al. Aging (Albany NY). 2021 Jul 19;13(14):18360-18375. doi: 10.18632/aging.203284. Epub 2021 Jul 19. Aging (Albany NY). 2021. PMID: 34282052 Free PMC article.

2

Mutations in WDR4 as a new cause of Galloway-Mowat syndrome.

Braun DA, Shril S, Sinha A, Schneider R, Tan W, Ashraf S, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Daga A, Warejko JK, Nakayama M, Schapiro D, Chen J, Airik M, Rao J, Schmidt JM, Hoogstraten CA, Hugo H, Meena J, Lek M, Laricchia KM, Bagga A, Hildebrandt F. Braun DA, et al. Am J Med Genet A. 2018 Nov;176(11):2460-2465. doi: 10.1002/ajmg.a.40489. Epub 2018 Aug 6. Am J Med Genet A. 2018. PMID: 30079490 Free PMC article.

3

Further delineation of the phenotype caused by biallelic variants in the WDR4 gene.

Trimouille A, Lasseaux E, Barat P, Deiller C, Drunat S, Rooryck C, Arveiler B, Lacombe D. Trimouille A, et al. Clin Genet. 2018 Feb;93(2):374-377. doi: 10.1111/cge.13074. Epub 2017 Sep 29. Clin Genet. 2018. PMID: 28617965

4

WDR4 promotes HCC pathogenesis through N⁷-methylguanosine by regulating and interacting with METTL1.

Dong R, Wang C, Tang B, Cheng Y, Peng X, Yang X, Ni B, Li J. Dong R, et al. Cell Signal. 2024 Jun;118:111145. doi: 10.1016/j.cellsig.2024.111145. Epub 2024 Mar 16. Cell Signal. 2024. PMID: 38493882

5

Structural insight into how WDR4 promotes the tRNA N7-methylguanosine methyltransferase activity of METTL1.

Jin X, Guan Z, Hu N, He C, Yin P, Gong Z, Zhang D. Jin X, et al. Cell Discov. 2023 Jun 27;9(1):65. doi: 10.1038/s41421-023-00562-y. Cell Discov. 2023. PMID: 37369656 Free PMC article. No abstract available.

6

WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas.

Han WY, Wang J, Zhao J, Zheng YM, Chai XQ, Gao C, Cai JB, Ke AW, Fan J, Gao PT, Sun HX. Han WY, et al. Cancer Lett. 2023 Aug 1;568:216259. doi: 10.1016/j.canlet.2023.216259. Epub 2023 Jun 4. Cancer Lett. 2023. PMID: 37279851

7

METTL1/WDR4-mediated tRNA m⁷G modification and mRNA translation control promote oncogenesis and doxorubicin resistance.

Wang Z, Yu P, Zou Y, Ma J, Han H, Wei W, Yang C, Zheng S, Guo S, Wang J, Liu L, Lin S. Wang Z, et al. Oncogene. 2023 Jun;42(23):1900-1912. doi: 10.1038/s41388-023-02695-6. Epub 2023 Apr 25. Oncogene. 2023. PMID: 37185458

8

Association of RNA m⁷G Modification Gene Polymorphisms with Pediatric Glioma Risk.

Zhu J, Liu X, Chen W, Liao Y, Liu J, Yuan L, Ruan J, He J. Zhu J, et al. Biomed Res Int. 2023 Jan 24;2023:3678327. doi: 10.1155/2023/3678327. eCollection 2023. Biomed Res Int. 2023. PMID: 36733406 Free PMC article.

9

Structural basis of regulated m⁷G tRNA modification by METTL1-WDR4.

Li J, Wang L, Hahn Q, Nowak RP, Viennet T, Orellana EA, Roy Burman SS, Yue H, Hunkeler M, Fontana P, Wu H, Arthanari H, Fischer ES, Gregory RI. Li J, et al. Nature. 2023 Jan;613(7943):391-397. doi: 10.1038/s41586-022-05566-4. Epub 2023 Jan 4. Nature. 2023. PMID: 36599985

10

Structures and mechanisms of tRNA methylation by METTL1-WDR4.

Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Ruiz-Arroyo VM, et al. Nature. 2023 Jan;613(7943):383-390. doi: 10.1038/s41586-022-05565-5. Epub 2023 Jan 4. Nature. 2023. PMID: 36599982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year